Top compounds associated with response to MYO19


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.2
mRNA staurosporine CTRPv2 pan-cancer AAC -0.1 0.2
mRNA FQI-1 CTRPv2 pan-cancer AAC 0.065 0.2
mRNA Bosutinib GDSC1000 pan-cancer AAC 0.045 0.2
mRNA triptolide CTRPv2 pan-cancer AAC 0.049 0.2
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.053 0.2
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.043 0.2
mRNA NSC-87877 GDSC1000 pan-cancer AAC -0.047 0.2
mRNA MLN4924 GDSC1000 pan-cancer AAC 0.051 0.2
mRNA CGP-082996 GDSC1000 pan-cancer AAC -0.072 0.2
Download CSV